Vaccine Fast Track – Samitivej Srinakarin Vaccine Fast Track – Samitivej Srinakarin

Vaccine Fast Track – Samitivej Srinakarin

Available through Dec 31, 2024

Vaccine Fast Track – Samitivej Srinakarin

Fast vaccinations, minimal wait times, swift return home. For adults and seniors.

Quadrivalent Influenza Vaccine
  • It should be administered annually as the strains of the disease change each year.
  • It is a single dose vaccine.
  • Recommended groups for the influenza vaccine include:
    • Elderly individuals.
    • Individuals with chronic diseases (such as chronic obstructive pulmonary disease, asthma, heart disease, stroke, kidney failure and diabetes), and cancer patients undergoing chemotherapy.
    • Individuals with brain disabilities who cannot help themselves.
    • Individuals with weakened immune systems, including those with Thalassemia, and HIV-infected individuals experiencing symptoms.
    • Obese individuals with a weight of over 100 kilograms or (BMI > 35 kg/m²).
Influenza Vaccine for Seniors 65+
Pneumococcal Vaccine
  • Suitable for adults, the elderly or individuals with chronic diseases such as diabetes, heart disease, kidney disease or lung disease.
  • For optimal immunity, it is recommended that individuals receive the 13-strain pneumococcal vaccine first, followed by the 23-strain pneumococcal vaccine at least 1 year later, which can provide lifelong protection.
  • Vaccination should be avoided in individuals with severe illness or fever, or in critically ill patients.
New Dengue Fever Vaccine
  • The vaccine's efficacy against all four serotypes of dengue fever is 80.2%, with hospitalization rates reduced by 90.4%.
  • It can be administered up to the age of 60.
  • It can be given to individuals who have or have not previously been infected with dengue fever without the need for a blood test.
  • Two doses are administered, spaced 3 months apart.
  • Contraindications: Due to it being a live attenuated vaccine type, the contraindications are similar to those of other live attenuated vaccines, including:
    • Individuals hypersensitive to important drug components or any added drug substance, or those hypersensitive to the previously administered dengue fever vaccines.
    • Individuals with congenital or acquired cellular immune deficiencies, including those undergoing immunosuppressive therapy such as chemotherapy or corticosteroids at immunosuppressive doses for more than 4 weeks prior to vaccination.
    • Individuals with symptomatic HIV infection, or asymptomatic HIV infection with evidence of impaired immune function.
    • Pregnant women or breastfeeding mothers.
Shingles Vaccine
  • This new vaccine is 97% effective in preventing shingles and 91.2% effective in preventing postherpetic neuralgia (PHN) in adults aged 50 and above.
  • The new vaccine can be administered to individuals aged 18 and older who are at a heightened risk of developing shingles, unlike the previous vaccine type that is contraindicated for this demographic.
  • Suitable for:
    • Individuals aged 50 and above with declining immune function.
    • Those who have had chickenpox and are at risk of shingles.
    • Patients with chronic diseases such as diabetes, lung disease, or kidney disease, including those who have had COVID-19.
    • Immunocompromised individuals such as organ or bone transplant recipients, individuals with autoimmune diseases like SLE, HIV positive individuals and those taking immunosuppressive drugs.
Vaccine Program  Promotion Price
(THB)
Influenza Vaccine for Adults  | Buy Now 990
1,490
Influenza Vaccine for Seniors 65+ | Buy Now 2,500
3,400
13-strain Pneumococcal Vaccine | Buy Now 3,699
4,900
23-strain Pneumococcal Vaccine  | Buy Now 3,000
3,600
New Dengue Fever Vaccine for Individuals Aged 15-60 (2 doses) | Buy Now 4,800
6,050
Shingles Vaccine (2 doses) | Buy Now 13,800
16,000

Terms and Conditions

  • These vaccine programs cannot be administered to children under 15 years old or pregnant women
  • Prices include doctor’s fees and hospital service fees
  • Receive services at the Vaccine Center, Samitivej Srinakarin Hospital